Clinical trial · Observational
Evaluation of a New Open Source Virtual Bronchoscope Navigation System
Fraxinus- Assessment of an Open Source Virtual Bronchoscopic Navigation System
NCT03745859CI-TRIAL-00091348terminatedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): necessary upgrades of essential software were not delivered
Summary
Brief summary (as posted)
To evaluate the feasibility of the Fraxinus Virtual Bronchoscope Navigation (VBN) System in the bronchoscopic access to target lesions. The study emphasizes the system´s efficacy in diagnostics of peripheral pulmonary lesions and the ease of use for the operator.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bronchial Neoplasms | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Fraxinus VBN system | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Evidence if the Fraxinus VBN System has a role in the assessment of peripheral pulmonary lesions
- timeFrame
- 48 hours
- description
- The proportion of cases in which the use of the system is considered beneficial
Secondary outcomes (4)
- measure
- Diagnostic yield
- timeFrame
- 1 week
- description
- Diagnostic success defined as cytology or biopsy with pathology
- measure
- Duration of procedure
- timeFrame
- 48 hours
- description
- Time spent with preparations and bronchoscopy
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * referred to thoracic department in any of the participating hospitals with undiagnosed peripheral pulmonary lesion(s) not visible by bronchoscopy * voluntary signed an informed consent Exclusion Criteria: * pregnancy * Any patient that the Investigator feels is not appropriate for this study for any reason
References
Publications (0)
Data not yet available
No reference posted for this study.